Procalcitonin Use in Pneumonia Patients in the Critical Care Setting

Mayo Clinic logo

Mayo Clinic

Status

Completed

Conditions

Pneumonia

Treatments

Other: Use of procalcitonin as biomarker to guide therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT01788488
12-008835

Details and patient eligibility

About

The goal of the study is to determine the impact of procalcitonin (PCT)-guided therapy on duration of antibiotic therapy in critical care unit (CCU) patients with suspected pneumonia at Mayo Clinic Health System Eau Claire.

Enrollment

134 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 years old
  • admitted to critical care unit
  • placed on pneumonia protocol

Exclusion criteria

  • patients who received outpatient antibiotic therapy within previous 21 days

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

134 participants in 2 patient groups

Standard Therapy
No Intervention group
Procalcitonin-guided therapy
Experimental group
Description:
Procalcitonin levels will be measured to determine when it is appropriate to discontinue antibiotic therapy.
Treatment:
Other: Use of procalcitonin as biomarker to guide therapy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems